期刊文献+

利伐沙班预防关节置换术后深静脉血栓效果的文献计量分析 被引量:4

Bibliometric Analysis on Rivaroxaban Preventive Effect on the Deep Vein Thrombosis after Arthroplasty
下载PDF
导出
摘要 目的总结近年来国内外在关节置换术后应用利伐沙班预防深静脉血栓(DVT)效果的文献计量分析。方法以关键词"利伐沙班、关节置换"为检索词,利用中国知网和万方数据库,检索语言为中文,检索时间2008年1月至2013年9月,计算机共检索出文献40篇;以"Rivaroxaban、arthroplasty"为关键词在Pubmed中检索,文献检索语种限制为英文,检索的研究对象为人类,检索时间限制在2008年1月至2013年9月,检索文献82篇。结果在2008-2013年中文文献分布中,已发表的中文文献有40篇,2009年最少,为0篇,2011年最多,前3年所发表的论文为5篇。从PubMed搜索到的关于利伐沙班预防关节置换术后静脉血栓的外文期刊有47种,符合检索条件的共78篇,发表文献最多的期刊是Lancet,有5篇,所占比例是6.41%。结论利伐沙班在关节置换术后预防DVT的疗效和安全性比一般药物好,建议在关节置换术后使用利伐沙班。 Objective To summarize the effect of rivaroxaban for the prevention of deep vein thrombosis (DVT) after arthroplasty at home and abroad in recent years. Methods With "rivaroxaban, arthroplasty" as the keywords for the search term, use Chinese National Knowledge Infrastructure, in Chinese language, search timeframeJan. 2008-Sep. 2013,13 literatures were retrieved by computers;with" rivaroxaban,arthroplasty" as the keywords for the search, searching for in Wan Fang, retrieval language is Chinese, retrieval time is 2008- 01/2013-09 ,the 27 literatures were found; " Rivaroxaban, arthroplasty" which are Keywords have been retrieved in Pubmed, the literature seareh language is limited by the English, retrieved the object of study is mankind, retrieval time is limitted in 2008-01/2013-09, retrieve documents 82. According to search criteria, 122 literatures were detected through the computer, the 30 of the which were analysed. Results In the Chinese literature distribution of 2008 -2013, Chinese literatures have been published 40, the 2009 is at least, don't one;The 2011 is at most,the previous three years,the papers published are only 5. From the PubMed, to search about rivaroxaban prevention of venous thremboembolism after joint replacement study literatures on the abroad in English have 47 kinds of journals,matching the search criteria for a total of 78 ,the most journal published literature calls the Lancet, there are five, its share ratio is 6.41%. Conclusion Aftert the arthroplasty, because the prevention about rivaroxaban of deep vein thrombosis of the efficacy and safety of the drugs were better than the general, so we recommend to use the rivaroxaban in arthroplasty.
出处 《医学综述》 2014年第9期1662-1665,共4页 Medical Recapitulate
关键词 利伐沙班 关节置换 深静脉血栓 效果 Rivaroxaban Arthroplasty Deep vein thrombosis Effect
  • 相关文献

参考文献23

  • 1Jay RL,Wellington KH.Prevention of venous thromboembolic disease after total hip and knee arthroplasty[J].J Bone Joint Surg Am,2005,87(9):2097-2112.
  • 2Elf JL,Nilsson C,Strandberg K,et al.Clinical probability assessment and D-dimer determination in patients with suspected deep vein thrombosis,a prospective multicenter management study[J].Thromb Res,2009,123(4):612-616.
  • 3Geerts WH,Bergqvist D,Pineo GF,et al.Prevention of venous thromboembolism:American College of Chest Physicians EvidenceBased Clinical Practice Guidelines(8th Edition)[J].Chest,2008,133(6 Suppl):381S-453S.
  • 4Freedman KB,Brookenthal KR,Fitzgerald RH Jr,et al.A metaanalysis of thromboembolie prophylaxis following elective total hip arthroplasty[J].J Bone Joint Surg Am,2000,82-A(7):929-938.
  • 5Broderick BJ,Breathnach O,Condon F,et al.Haemodynamic performance of neuromuscular electrical stimulation(NMES)during recovery from total hip arthroplasty[J].J Orthop Surg Res,2013,8(3):1-8.
  • 6Kim KI,Kang DG,Khurana SS,et al.Thromboprophylaxis for deep vein thrombosis and pulmonary embolism after total joint arthroplasty in a low incidence population[J].Knee Surg Relat Res,2013,25(2):43-53.
  • 7Bates D,Dalton B,Gilmour J,et al.Venous thromboembolism due to suspected interaction between rivaroxaban and nevirapine[J].Can J Hosp Pharm,2013,66(2):125-129.
  • 8Perzborn E,Kubitza D,Misselwitz F.Rivaroxaban.A novel,oral,direct factor Xa inhibitor in clinical development for the prevention and treatment of thromboembolic disorders[J].Hamostaseologie,2007,27(4):282-289.
  • 9Kwong LM.Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery:focus on rivaroxaban[J].Clin Pharmacol,2013,2(5):143-148.
  • 10Kubitza D,Becka M,Wensing G,et al.Safety,pharmacodynamics,and pharmacokinetics of BAY 59-7939—an oral,direct Factor Xa inhibitor-after multiple dosing in healthy male subjects[J].Eur J Clin Pharmacol,2005,61(12):873-880.

二级参考文献22

  • 1TURPIE AG. New oral anticoagulants in atrial fibrillation[J]. Eur Heart J, 2008, 29(2) : 155-165.
  • 2HIRSH J, FUSTER V, ANSELL J, et al. American heart association/American college of cardiology foundation guide to warfarin therapy[J]. Circulation, 2003, 107(12): 1692-1711.
  • 3REIFFEL JA. Will direct thrombin inhibitors replace warfarin for preveting embolic events in atrial fibrillation [J]. Curr Opin Cardiol, 2004, 19(1) : 58-63.
  • 4HOPFNER R. Ximelagatran (AstraZeneca)[J]. Curr Opin Investig Drugs, 2002, 3(2): 246-251.
  • 5Exeutive Steering Committee of the SPORTIF Ⅲ investigators. Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with nonvalvular atrial fibrillation (SPORTIF Ⅲ ): randomized controlled trial[J]. Lancet, 2003, 362(9397) : 1691-1698.
  • 6HALPERIN JL, Executive steering committee, SPORTIF Ⅲ and V Study Investigators. Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF Ⅲ and V) [J]. Am Heart J, 2003, 146(3): 431-438.
  • 7TEITELBAUM JS, yon KUMMER R, GJESDAL K, et al. Effect of ximelagatran and warfarin on stroke subtypes in atrial fibrillation[J]. Can J Neurol Sci, 2008, 35(2) : 160-165.
  • 8TESTA L, van GAAL W, AQOSTONI P, et al. Ximelagatran versus warfarin in the prevention of atrial fibrillation-related stroke: both sides of the story[J]. Stroke, 2007, 38(7): e57.
  • 9STANQIER J, STAHLE H, RATHGEN K, et al. Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects[J]. Clin Pharmacokinet, 2008, 47(1): 47-59.
  • 10HOLMES M, CARROLL C, PAPAIOANNOU D, et al. Dabigatran etexilate for the prevention of venous thromboembolism in patients elective hip and knee surgery: a single technology appraisa[J]. Health Technnl Assess, 2009, 13 Suppl.2: 55-62.

共引文献5

同被引文献47

  • 1邱贵兴,杨庆铭,余楠生,翁习生,王凯,李晓林.低分子肝素预防髋、膝关节手术后下肢深静脉血栓形成的多中心研究[J].中华骨科杂志,2006,26(12):819-822. 被引量:426
  • 2Meier PP, Engstrom JL, Patel AL, et al. Improving the Use of Human Milk During and After the NICU Stay[J]. Clin Perinatol, 2010,37 ( 1 ) : 217-245.
  • 3Bozzetti V, Tagliabue P. Disease in preterm newborn: an update on nutritional issues [J]. Ital J Pediatr, 2009,35 (1) :20.
  • 4Kempley ST,Sinha AK,Thomas MR. Which mikl for the sick preterm infant[J]. Current Paediatrics,2005,15:390- 399.
  • 5Patel AL, Engstrom JL, Meier PP, et al. Calculating post-venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)[J]. Chest,2008,133(6 Suppl) :S381-453.
  • 6Eisele R,Kinzl L, Koelsch T. Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis[J]. J Bone Joint Surg Am, 2007,89 (5) : 1050- 1056.
  • 7Silbersack Y, Taute BM, Hein W, et al. Prevention of deep-vein thrombosis after total hip and knee replace- ment. Low-molecular-weight heparin in combination with intermittent pneumatic compression [J]. J Bone Joint Surg Br, 2004,86 (6) : 809-812.
  • 8Westrich GH, Sculco TP. Prophylaxis against deep ve- nous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin a- lone[J]. J Bone Joint Surg Am, 1996,78 (6) : 826-834.
  • 9中国骨科大手术静脉血栓栓塞症预防指南[J].中华骨科杂志,2009,29(6):602-604. 被引量:528
  • 10马海梅,张会英,朱广玉,周乙雄.人工髋关节置换术围手术期凝血、抗凝活性变化[J].中华实用诊断与治疗杂志,2009,23(7):646-647. 被引量:19

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部